Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
53,705,899
-
Share change
-
+45,254,233
-
Total reported value
-
$56,392,538
-
Price per share
-
$1.05
-
Number of holders
-
61
-
Value change
-
+$47,402,399
-
Number of buys
-
44
-
Number of sells
-
13
Institutional Holders of GENOCEA BIOSCIENCES INC - COM (GNCA) as of Q1 2018
As of 31 Mar 2018,
GENOCEA BIOSCIENCES INC - COM (GNCA) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,705,899 shares.
The largest 10 holders included
NEA Management Company, LLC, Vivo Capital, LLC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, Polaris Venture Management Co. V, L.L.C., Alyeska Investment Group, L.P., NORTHERN TRUST CORP, STATE STREET CORP, and FMR LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.